NCT04070846View on ClinicalTrials.gov

Mass Balance Study of [14C]LC350189 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

March 7, 2020

Study Completion Date

March 7, 2020

Conditions

GoutHyperuricemia

Interventions

DRUG

[14C] LC350189

Carbon-14 labelded LC350189

Trial Locations (1)

78744

PPD, Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LG Chem

INDUSTRY

NCT04070846 - Mass Balance Study of [14C]LC350189 in Healthy Volunteers | Biotech Hunter | Biotech Hunter